New draft guidance for SaMD Will the changes affect you?

Join RAPS for a 2-day workshop

19-20 November 2019 | Rockville, MD


Regulatory Focus

GAO: Drugmakers Have Mixed Views on FDA, FTC REMS Actions

15 November 2019 | By Michael Mezher 

A report from the Government Accountability Office (GAO) released Thursday finds that generic and branded drugmakers are split over ...

Regulatory Exchange

Regulatory Intelligence

Help your organization maintain an edge with the latest actionable information